279 related articles for article (PubMed ID: 34518441)
1. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
2. SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer.
Gao T; Jiang B; Zhou Y; He R; Xie L; Li Y
Front Immunol; 2024; 15():1369892. PubMed ID: 38707897
[TBL] [Abstract][Full Text] [Related]
3. TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer.
Cheng X; Fan K; Wang L; Ying X; Sanders AJ; Guo T; Xing X; Zhou M; Du H; Hu Y; Ding H; Li Z; Wen X; Jiang W; Yan X; Ji J
Cell Death Dis; 2020 Feb; 11(2):92. PubMed ID: 32024821
[TBL] [Abstract][Full Text] [Related]
4. Immune cell infiltration and prognostic index in cervical cancer: insights from metabolism-related differential genes.
Ma B; Ren C; Yin Y; Zhao S; Li J; Yang H
Front Immunol; 2024; 15():1411132. PubMed ID: 38840928
[TBL] [Abstract][Full Text] [Related]
5. Identification of Breast Cancer Subtypes Based on Endoplasmic Reticulum Stress-Related Genes and Analysis of Prognosis and Immune Microenvironment in Breast Cancer Patients.
Yi C; Yang J; Zhang T; Qin L; Chen D
Technol Cancer Res Treat; 2024; 23():15330338241241484. PubMed ID: 38725284
[No Abstract] [Full Text] [Related]
6. Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer.
Huang D; Shen J; Zhai L; Chen H; Fei J; Zhu X; Zhou J
Front Immunol; 2021; 12():812713. PubMed ID: 35069601
[TBL] [Abstract][Full Text] [Related]
7. Calcium-sensing Receptor, a Potential Biomarker Revealed by Large-scale Public Databases and Experimental Verification in Metastatic Breast Cancer.
Xie W; Xu H; Cheng Y; Lin X; Zeng J; Sun Y
Technol Cancer Res Treat; 2024; 23():15330338241254219. PubMed ID: 38780484
[TBL] [Abstract][Full Text] [Related]
8. VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification.
Xia X; Xu F; Dai D; Xiong A; Sun R; Ling Y; Qiu L; Wang R; Ding Y; Lin M; Li H; Xie Z
Biosci Rep; 2024 May; 44(5):. PubMed ID: 38639057
[TBL] [Abstract][Full Text] [Related]
9. NLRP12 is a prognostic biomarker and correlated with immune infiltrates in epithelial ovarian cancer.
Ma R; Tang Z; Wang J
J Gene Med; 2024 Jan; 26(1):e3585. PubMed ID: 37926491
[TBL] [Abstract][Full Text] [Related]
10. Role of ALOX5 in non-small cell lung cancer: A potential therapeutic target associated with immune cell infiltration.
Zhao Q; Sun Z; Pan Y; Jing Q; Li W; Wang C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):311-322. PubMed ID: 37164914
[TBL] [Abstract][Full Text] [Related]
11. PNOC Expressed by B Cells in Cholangiocarcinoma Was Survival Related and LAIR2 Could Be a T Cell Exhaustion Biomarker in Tumor Microenvironment: Characterization of Immune Microenvironment Combining Single-Cell and Bulk Sequencing Technology.
Chen Z; Yu M; Yan J; Guo L; Zhang B; Liu S; Lei J; Zhang W; Zhou B; Gao J; Yang Z; Li X; Zhou J; Fan J; Ye Q; Li H; Xu Y; Xiao Y
Front Immunol; 2021; 12():647209. PubMed ID: 33841428
[TBL] [Abstract][Full Text] [Related]
12. CLEC11A expression as a prognostic biomarker in correlation to immune cells of gastric cancer.
Fang W; Wan D; Yu Y; Zhang L
Biomol Biomed; 2024 Jan; 24(1):101-124. PubMed ID: 37597212
[TBL] [Abstract][Full Text] [Related]
13. M1 Polarization Markers Are Upregulated in Basal-Like Breast Cancer Molecular Subtype and Associated With Favorable Patient Outcome.
Hachim MY; Hachim IY; Talaat IM; Yakout NM; Hamoudi R
Front Immunol; 2020; 11():560074. PubMed ID: 33304345
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Molecular Analyses of an M2-Like Tumor-Associated Macrophage for Predicting the Prognosis and Immunotherapy in Breast Cancer.
Chang K; Yue Q; Jin L; Fan P; Liu Y; Cao F; Zhang Y
J Immunother; 2024 Jul-Aug 01; 47(6):205-215. PubMed ID: 38686904
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer clinical outcomes and tumor immune microenvironment: cross-dialogue of multiple epigenetic modification profiles.
Teng C; Song X; Fan C; Man S; Hu Y; Hou Y; Xin T
Aging (Albany NY); 2024 May; 16(10):8998-9022. PubMed ID: 38796789
[TBL] [Abstract][Full Text] [Related]
16. Exploring GZMK as a prognostic marker and predictor of immunotherapy response in breast cancer: unveiling novel insights into treatment outcomes.
Li Z; Xie Q; Zhao F; Huo X; Ren D; Liu Z; Zhou X; Shen G; Zhao J
J Cancer Res Clin Oncol; 2024 Jun; 150(6):286. PubMed ID: 38833021
[TBL] [Abstract][Full Text] [Related]
17. The potent potential of MFAP2 in prognosis and immunotherapy of triple-negative breast cancer.
Huang J; Xu Y; Qi S; Zheng Q; Cui C; Liu L; Liu F
Discov Oncol; 2024 Jun; 15(1):202. PubMed ID: 38822944
[TBL] [Abstract][Full Text] [Related]
18. PROS1 shapes the immune-suppressive tumor microenvironment and predicts poor prognosis in glioma.
Wang J; Wu N; Feng X; Liang Y; Huang M; Li W; Hou L; Yin C
Front Immunol; 2022; 13():1052692. PubMed ID: 36685506
[TBL] [Abstract][Full Text] [Related]
19. Analyzing the Functional Roles and Immunological Features of Chemokines in COAD.
Xu H; Song Y
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791448
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Analysis of the Expression, Prognosis, and Immune Infiltrates for Chromodomain-Helicase-DNA-Binding Proteins in Breast Tumor.
Hasanlu M; Amiri-Dashatan N; Farahani M; Koushki M; Ahmadi H; Parsamanesh N; Ahmadi NA
Asian Pac J Cancer Prev; 2024 May; 25(5):1547-1558. PubMed ID: 38809626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]